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Abstract
Background Sarcopenia often co-occurs with osteoporosis in cross-sectional studies. However, this association has
rarely been studied in prospective studies. This study aimed to investigate the association between sarcopenia catego-
ries—along with its individual components—and incident osteoporosis in both middle-aged and older men and women
from the UK Biobank study.
Methods A total of 168,682 participants (48.8% women, aged 37 to 70 years at baseline) were included in this pro-
spective study. Categories of sarcopenia (pre-sarcopenia and sarcopenia), and its individual components, were defined
according to the EWGSOP2 criteria (2019). Associations with incident osteoporosis by sex were investigated using
Cox-proportional hazard models adjusted for socio-demographic, lifestyle and health-related factors, and morbidity
count. Associations between categories of sarcopenia and incident osteoporosis were also investigated by age-groups
and subtype of osteoporosis (with and without pathological fractures).
Results After a median follow-up of 7.4 years, 6296 participants were diagnosed with osteoporosis. When the analyses
were adjusted for a range of relevant confounding factors, pre-sarcopenia was associated with 1.3-times higher risk of
osteoporosis in men (HR: 1.30 [95% CI: 1.03 to 1.63]) but not in women, and sarcopenia was associated with 1.66-
times increased osteoporosis risk in women (HR: 1.66 [95% CI: 1.33 to 2.08]) but not in men compared with people
without sarcopenia or pre-sarcopenia. A similar magnitude of associations was found in osteoporosis without patholog-
ical fractures but weaker for those with pathological fractures. Within the individual components, low muscle mass
(HRwomen: 1.36 [95% CI: 1.22 to 1.51] and HRmen: 3.07 [95% CI: 1.68 to 5.59]), followed by slow gait speed (HRwomen:
1.30 [95% CI: 1.17 to 1.45] and HRmen: 1.70 [95% CI: 1.43 to 2.02]), were associated with a higher risk of incident
osteoporosis in both sexes. Low grip strength was associated with a higher risk of incident osteoporosis in men (HR:
1.38 [95% CI: 1.15 to 1.65]), but not in women. No significant interaction between the exposures and incident osteo-
porosis by age groups were identified.
Conclusions Our findings demonstrated that pre-sarcopenic men and sarcopenic women had a higher risk of develop-
ing osteoporosis even after adjustment for a large range of potential confounders. Considering that sarcopenia could be
prevented, health interventions to improve physical capability may delay or prevent the onset of osteoporosis.
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Introduction
Osteoporosis is the result of changes in bone turnover that
reduces bone mineral density (BMD), increase bone fragility,
and predispose to fragility fractures along with a higher bur-
den of morbidity and mortality.1 Clinically, osteoporosis is
identified as a BMD more than 2.5 standard deviations (SD)
below the mean value in younger and healthy individuals
(a T-score of <2.5 SD).2,3 According to the International Os-
teoporosis Foundation, in 2017, approximately 2.8 million
people older than 50 years had osteoporosis in the United
Kingdom, while fragility fractures, associated with osteoporo-
sis, are the fourth most common chronic disease after ischae-
mic heart disease, dementia, and lung cancer.4 Moreover, the
economic burden and healthcare costs linked to osteoporosis
are also high. In 2017, the economic cost of the disease in the
United Kingdom was £4.5 billion; however, this is projected to
rise to £5.9 billion by 2030.4 Therefore, it is important to
ascertain risk factors for osteoporosis that help us identify
high-risk individuals and develop interventions aimed at pre-
vention or early treatment, in order to reduce the personal
and economic burden of osteoporosis.
Although several risk factors have been linked to a
higher risk of osteoporosis, the evidence has not been
unequivocal.1,5,6 Some of the well-recognized risk factors
for osteoporosis include older age, white ethnic background,
post-menopause in women, weight loss, smoking, excessive
alcohol intake, vitamin D deficiency (lack of sunlight
exposure), inadequate intake of calcium (lower than
1000 mg/day), low protein intake (lower than 0.8 g/kg/body
weight) as well as lack of physical activity. Muscle weakness
has also been associated with a higher risk of osteoporosis in-
dependently of physical activity.5,6 In keeping with this find-
ing, the age-related decline in muscle quantity and quality,
known as sarcopenia, also affects mobility, bone mass, and
bone microarchitecture. In fact, existing evidence has sug-
gested that sarcopenia may be an independent predictor of
low BMD and fragility fractures, that is, osteoporosis.7–12
Previous studies have reported that sarcopenia and osteo-
porosis often co-occur.7,8,10–12 A recent meta-analysis identi-
fied that the prevalence of osteoporosis and sarcopenia in
white European aged 65 years or older varied between
5.0% and 37.0%.13 Unfortunately, the cross-sectional nature
of most existing evidence has limitations and does not allow
further understanding of the association between sarcopenia
and osteoporosis. In terms of prospective evidence, the ma-
jority of these studies have investigated the association be-
tween individual physical capability markers and sarcopenia
with fracture risk14–22 and have been conducted on smaller
samples (n < 5000) or focused mainly on older adults. Also,
to our knowledge, there are no studies which have investi-
gated the prospective association between sarcopenia and
incident osteoporosis per se. Therefore, this study aimed to
investigate the association between sarcopenia categories—
along with its individual components—and incident osteopo-
rosis in both middle-aged and older men and women, using
data from UK Biobank, a large prospective cohort study.
Methods
Over 500,000 participants (5.5% response rate), aged 37 to
73 years, were recruited from the general population be-
tween 2006 and 2010 to be part of UK Biobank.23 In brief,
participants attended their closest assessment centre across
Scotland, England, and Wales24,25 where they completed a
touch-screen questionnaire, had physical measurements
taken, and provided blood, urine, and saliva sample at base-
line. More information about the UK Biobank protocol can
be found online (http://www.ukbiobank.ac.uk).
Incident osteoporosis
Incident osteoporosis cases were ascertained through linkage
of primary care records. Diagnosis of osteoporosis was pri-
marily based on dual-energy X-ray absorptiometry (DXA) scan
results. However, women>75 years that experienced a fragil-
ity fracture may be diagnosed with osteoporosis prior to a
DXA scan. Currently, this information was available only for
45% of the UK Biobank cohort (~230,000 participants) until
May 2017 for Scotland, September 2017 for Wales, and
August 2017 for England. The detailed linkage procedures re-
lating to primary care records are available at http://biobank.
ndph.ox.ac.uk/showcase/showcase/docs/primary_care_data.
pdf. Therefore, the analyses of incident osteoporosis cases
were restricted to the 228,481 participants with linkage to
primary care records. Follow-up was censored at the primary
care data end-date for the relevant country or the date
of incident osteoporosis. Osteoporosis was defined as M80
(osteoporosis with pathological fracture) M81 (osteoporosis
without pathological fracture) or M82 (osteoporosis in dis-
eases classified elsewhere) using the International Classifica-
tion of Diseases, 10th revision (ICD-10).
Sarcopenia and its components
Muscle mass index was derived from skeletal muscle mass
(kg) divided by height (m) squared using the total body com-
position measured via bioimpedance (BIA, Tanita BC418MA,
Tokyo, Japan) by trained nurses. To estimate skeletal muscle
mass, the Janssen equation was utilized.26 Following
the European Working Sarcopenia in Older People 2019
(EWGSOP2) recommendations, the cut-off points used were
<7.0 kg/m2 in men and <5.5 kg/m2 in women. Grip strength
was measured using a Jamar J00105 hydraulic hand dyna-
mometer. The mean of the right and left values was derived
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and expressed in absolute units (kg). The cut-off points ap-
plied to define low grip strength were <27 kg in men and
<16 kg in women.27 Self-reported walking pace was used as
a proxy of gait speed and categorized as slow, average or
brisk. A previous study determined that self-reported walking
pace is a good marker of walking speed.28 To derive a proxy
for gait speed, this was then dichotomized into slow or
normal (average or brisk pace).
Using these three physical capability markers, sarcopenia
was classified in accordance with the EWGSOP2 statement
as pre-sarcopenia, defined as low grip strength only (other
physical capability markers in the normal range); sarcopenia,
defined as low grip strength plus low muscle mass27; and se-
vere sarcopenia, defined as the combination of sarcopenia
and slow gait speed. However, because of the low number
of UK Biobank participants with severe sarcopenia (n = 87),
sarcopenia and severe sarcopenia were pooled together
(hereafter referred to as sarcopenia). We followed this ap-
proach to avoid unreliable and unpowered hazard ratios
(HR) estimates. The pre-sarcopenia and sarcopenia groups
were mutually exclusive. For this study, only white European
participants were included because of the ethnic differences
in the reference values for sarcopenia.27
Covariates
Age at baseline was calculated from dates of birth and base-
line assessment. Area-based socioeconomic deprivation was
derived from postcode of residence, using the Townsend
score.29 Self-reported smoking status was categorized as
never, former or current smoker. Physical activity was
self-reported using the International Physical Activity Ques-
tionnaire short form30 and total physical activity was com-
puted as the sum of walking, moderate and vigorous
activity, measured as metabolic equivalents (MET-hours/
week). Prevalent morbidity was ascertained during a
nurse-led interview at baseline. We calculated morbidity
count based on 43 long-term conditions originally developed
for a large epidemiological study in Scotland and subse-
quently adapted for UK Biobank.31 Body composition was
measured using BIA by trained nurses. Frequency of alcohol
intake was self-reported at baseline and categorized as
daily/almost daily, three to four times a week, once/twice a
week, one to three times a month, special occasions only
and never. Corticosteroid and H2 blockers use, as well as
menopause and hypogonadism, were self-reported at base-
line. History of fall and fractures were self-reported at base-
line using these two questions: ‘In the last year, have you
had any falls?’ and ‘have you fractured/broken any bones in
the last five years?’ Vitamin D levels were assessed by
25-hydroxyvitamin D (25(OH)D) concentration in serum. Red
and processed meat intake were collected through the
touch-screen questionnaire at baseline. Finally, calcium and
protein intake were estimated via the Oxford WebQ, a web-
based 24-h recall questionnaire.32 For the 71,673 participants
who completed more than one the average dietary of the
24-h recall, this average intake was used. Further details of
these measurements can be found in the UK Biobank online
protocol (http://www.ukbiobank.ac.uk).
Ethical approval
UK Biobank was given favourable opinion by the North West
Multi-Centre Research Ethics Committee (Ref: 11/NW/0382).
The study protocol is available online (http://www.
ukbiobank.ac.uk/). This work was conducted under the UK
Biobank application number 7155.
Statistical analyses
Descriptive characteristics are presented as means with stan-
dard deviations (SD) for quantitative variables, and as fre-
quencies and percentages for categorical variables by sex.
Associations between categories of sarcopenia (pre-
sarcopenia and sarcopenia) and incident osteoporosis were
investigated using Cox-proportional hazard models stratified
by sex. Non-sarcopenic individuals (i.e. with the three physi-
cal capability markers in the normal range) were used as
the reference group. The results are reported as HR and their
95% confidence intervals (95% CIs). The proportional hazard
assumptions were checked using Schoenfeld residuals. Asso-
ciations between the three individual physical capability
markers (low grip strength, low muscle mass and slow gait
speed) and incident osteoporosis were investigated using
the same analysis. For each component, the normal range
of the physical capability maker defined by the EWGSOP2
was used as the reference group.27 Participants who
self-reported osteoporosis at baseline were excluded from
all analyses (n = 3472). Only participants with complete data
available for the three physical capability markers used to de-
fine later categories of sarcopenia, the covariates included in
the analyses, and incident osteoporosis were included.
Follow-up time was used as the time-dependent variable.
We ran five models including an increasing number of co-
variates: model 1 (minimally adjusted) included
socio-demographic covariates (age and deprivation); model
2 additionally included lifestyle and health-related factors:
smoking, physical activity, alcohol intake and consumption
of red and processed meat, body fat, and morbidity count
at baseline (based on 43 diseases and coded as 1, 2, 3, 4
and ≥5). Model 3, as model 2, but additionally adjusted for
serum vitamin D levels, use of corticosteroids and H2
blockers, falls, fractures over the previous 5 years, and
menopause and hypogonadism in women and men, respec-
tively. These covariates were chosen as they are potentially
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causal for sarcopenia and osteoporosis. Two sensitivity analy-
ses were also performed: model 4, as per model 3, but using
a 2-year landmark period which excluded participants who
experienced events within the first 2 years of follow-up
(1323 women and 290 men) to minimize potential reverse
causation; and model 5, as per model 3, but further adjusted
for calcium and protein intake (as these variables were avail-
able in 71,673 participants only). Additionally, the association
of categories of sarcopenia with subtypes of osteoporosis
outcomes (split out by pathological fractures and osteoporo-
sis without pathological fractures [or classified elsewhere])
was also investigated.
The sex-specific cumulative crude hazard rate of incident
osteoporosis and categories of sarcopenia was estimated
using the Nelson–Aalen estimator. Finally, to investigate
whether the associations between categories of sarcopenia
and incident osteoporosis differed by age, the models were
re-run stratified by the following age categories: (i) approxi-
mately when menopause or hypogonadism start (≥45 and
<45 years as well as ≥55 and <55 years), (ii) using different
definitions for aging (≥60 and <60 years as well as ≥65 and
<65 years).
Stata 16 statistical software (StataCorp LP) was used to
perform all analyses.
Results
After removing people who withdrew during the follow-up,
228,477 of the 502,488 UK Biobank participants had data
available for incident osteoporosis. Excluding people with
missing data for one or more physical capability marker
(n = 2080), osteoporosis at baseline (n = 3472), non-white
ethnicity (n = 10,832) or incomplete covariate data
(n = 43,411), 168,682 participants (48.8% women) had data
available on all essential variables (Figure 1). Of these,
154,429 could be classified as non-sarcopenia, pre-
sarcopenia, or sarcopenia (Supporting Information, Figure
S1). After a median follow-up of 7.4 years (interquartile range
6.7 to 8.2 years), 6296 (3.7%) participants were diagnosed
with osteoporosis.
The baseline characteristics of participants by sarcopenia
categories and sex are shown in Table 1. Briefly, 5950
(8.0%) of the 74,293 women and 4075 (5.1%) of the 80,136
men were pre-sarcopenic or sarcopenic. Overall, compared
with non-sarcopenic individuals, both men and women with
pre-sarcopenia or sarcopenia were older, more likely to cur-
rently smoke, use H2 blockers and/or corticosteroids, and re-
port never drinking alcohol. They had lower levels of physical
activity and reported a lower intake of protein and calcium.
They were also more likely to have more than one morbidity,
and to have had fractures in the last 5 years and falls in the
last year. Lastly, pre-sarcopenic and sarcopenic individuals
were more likely to be postmenopausal (women) and report
hypogonadism (men) compared with non-sarcopenic women
and men, respectively (Table 1). The baseline characteristics
by individual physical capability marker by sex are shown in
Tables S1 to S3.
Sex-specific associations between sarcopenia categories
and incident osteoporosis are shown in Figure 2 and
Table S4. In the minimally adjusted model (model 1), a higher
risk of incident osteoporosis was identified in sarcopenic
Figure 1 Flow diagram participants included in the study. EWGSOP2, European working sarcopenia in older people 2019.
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women compared to non-sarcopenic (HR: 2.01 [95% CI: 1.61
to 2.51]). The association was attenuated after adjustment
for lifestyle factors, body composition and morbidity count
(model 2) and remained significant in model 3 (HR: 1.66
[95% CI: 1.33 to 2.08]). The results were similar in the
2-year landmark analysis (model 4). However, the association
were no longer present when protein and calcium intake
were included as covariates (model 5). No associations were
identified between pre-sarcopenic women and incident
osteoporosis. Incident osteoporosis without pathological
fractures showed similar patterns of associations (Table S5).
Additionally, pre-sarcopenic women showed a higher risk of
incident osteoporosis using this outcome (HRmodel 3: 1.15
[95% CI: 1.01 to 1.32]). Non-significant associations were
identified between categories of sarcopenia and osteoporosis
with pathological fractures.
The risk of osteoporosis in pre-sarcopenic and sarcopenic
men was 1.40- and 4.97-times higher, respectively, in compar-
ison to non-sarcopenic men in the minimally adjusted model
(model 1). The associations were attenuated when the analy-
sis was further adjusted for morbidity count, lifestyle and
health-related factors (models 2 and 3) for sarcopenic men
but remained significant for pre-sarcopenic men (HR: 1.30
[95% CI: 1.03 to 1.63]) (Figure 2). As per women, a similar
trend was identified when a two-year landmark was included
in the analysis but disappeared when protein and calcium in-
take were included (model 5, Table S4). When the subtypes
of osteoporosis were used as outcomes, we observed a
similar magnitude of association between pre-sarcopenic
men and osteoporosis without pathological fractures. The
associations with the pathological fracture incidence were
non-significant (Table S5). On the other hand, regarding the
cumulative hazard estimate, both men and women with
sarcopenia had a steeper crude cumulative incidence of oste-
oporosis than non-sarcopenic men and women, respectively
(Figures S2 and S3).
Of the three physical capability markers used to define cat-
egories of sarcopenia, slow gait speed and low muscle mass
were independently associated with 1.30- and 1.36-times
higher risk of incident osteoporosis in women and 1.70- and
3.07-times higher risk of incident osteoporosis in men, re-
spectively (Figure 3, model 3). The associations remained
when the analyses were further adjusted for protein and cal-
cium intake and in the two-year landmark analysis (except for
low muscle mass in men, probably due to the few numbers of
cases). Low grip strength was associated with a higher risk of
incident osteoporosis in men across all models (HRmodel
3:1.38 [95% CI: 1.15 to 1.65]), but not in women. Based on
model 3, low muscle mass was the physical capability marker
associated with the highest risk of incident osteoporosis in
both sexes.
Finally, while there were no significant interactions with
age-group, the numerical magnitude of the associations be-
tween sarcopenia and incident osteoporosis was higher in
the older age-group for sarcopenic women and pre-
sarcopenic men compared to their counterparts (Table S6).
Discussion
Sarcopenia and osteoporosis are prevalent conditions that
are associated with substantial health burden.1 After adjust-
ment for a wide range of potential confounding factors,
pre-sarcopenia was associated with a higher risk of incident
osteoporosis in men, but not in women, while sarcopenia
was associated with a higher risk in women, but not in
men. The lack of association between sarcopenic men and in-
cident osteoporosis might be related to the low number of
sarcopenic men in our study; therefore, this analysis was
probably underpowered. These results were consistent for in-
dividuals without pathological fractures but not for those
with osteoporosis with pathological fractures. The latter rein-
forces the relevance of the early assessment of sarcopenia in
these individuals beyond fractures. Among the three physical
capability markers used to define sarcopenia, low muscle
mass was associated with the highest risk of incident
osteoporosis in both sexes, followed by slow gait speed
Figure 2 Association between categories of sarcopenia and osteoporosis incidence by sex. Analyses are presented as HR with their respectively CI.
Non-sarcopenic participants were used as the reference group. Analyses were adjusted by socio-demographic factors (age and deprivation), morbidity
count, physical activity, smoking, alcohol and red and processed meat intake, body fat, serum vitamin D levels, corticosteroids, H2 blockers, falls and
fractures in the last 5 years and menopause in women and hypogonadism in men (model 3). *Sarcopenia includes those with sarcopenia or severe
sarcopenia.
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(in both sexes) and low grip strength (in men only). Given
these findings, and considering the health and economic bur-
den of osteoporosis in the United Kingdom,4 preventing, di-
agnosing and treating sarcopenia might help prevent or
delay some cases of osteoporosis and the significant health
and financial burden associated with this, assuming causality.
As the decrease in muscle mass starts at ~40 years,27 and this
leads to a higher risk of falls and fragility fractures, interven-
tions improving or maintaining decent physical capability
levels in middle and older ages are needed.
The association between sarcopenia and osteoporosis has
been previously studied, but most evidence comes from
cross-sectional studies.7,8,10–12 To our knowledge, this is the
first study reporting the longitudinal association between
sarcopenia and incident osteoporosis. Previous prospective
studies often used fractures as a proxy for osteoporosis, even
though all fractures may not necessarily indicate osteoporosis
and, as it was demonstrated in our study, pre-sarcopenic men
and sarcopenic women had a higher risk of osteoporosis
without pathological fractures. In terms of fracture studies,
Yu et al. used the MrOs study to report that sarcopenia was
an independent risk factor for fractures in men (HR: 1.87
[95% CI: 1.30 to 2.68]), but not in women (HR: 0.80 [95%
CI: 0.49 to 1.31]).19 Similarly, Scott et al. identified that
sarcopenic obese community-dwelling older men had more
than 3-times higher rate of self-reported fractures compared
to non-sarcopenic non-obese men. Sarcopenic obese women,
in contrast, had a higher risk of fracture compared with obese
women (incident rate ratio: 2.82 [95% CI: 1.42 to 5.60]), but
this was mediated by BMD (incident rate ratio: 1.93 [95%
CI: 0.94 to 3.98]).20 In comparison to our study, these studies
used different classifications to define sarcopenia, their out-
come was the risk of fracture instead of osteoporosis itself,
and included only older individuals. The latter reinforces the
relevance of our findings which identified an increased risk
of osteoporosis in both sexes (women with sarcopenia and
men with pre-sarcopenia) using the latest guidelines sug-
gested for the EWGSOP2,27 in both middle-aged and older
adults.
In terms of the individual components used to define
sarcopenia, the majority of previous studies have investigated
their association with risk fractures as an outcome.14,16,17
Only a few studies have also reported the association of
these individual factors with osteoporosis or fragility frac-
tures associated with osteoporosis.15,33,34 Cheung et al., using
a subset of 1702 participants from the prospective Hong Kong
Osteoporosis study, found that grip strength was strongly as-
sociated with fragility fractures and osteoporosis at the hip.33
Likewise, for each standard deviation lower in gait speed,
there was a 2.16-times higher risk of hip fractures and
1.33-times higher risk of major osteoporotic fractures among
351 post-menopausal women who were followed up for
Figure 3 Associations between individual physical capability markers and incident osteoporosis by sex. Analyses are presented as HR with their respec-
tively CI. Non-sarcopenic participants were used as the reference group. Analyses were adjusted by model 1, adjusted by socio-demographic factors
(age and deprivation); model 2 as model 1, but additionally morbidity count, physical activity, smoking, body fat, alcohol and red and processed meat
intake. Model 3, as model 2, but additionally adjusted by serum vitamin D levels, corticosteroids, H2 blockers, falls and fractures in the last 5 years and
menopause in women and hypogonadism in men. Model 4, as per model 3, but using a 2-year landmark that excluded participants who experienced
events within the first 2 years of follow-up; and model 5, as per model 3, but further adjusted for calcium and protein intake.
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10 years.34 In Canada, after 6 years follow-up of 9622 men
and women older than 40 years, Leslie et al. identified that
a decrease in total body lean mass was independently associ-
ated with an increased risk of osteoporotic fractures.15
As a prospective study of osteoporosis, rather than a proxy,
the current study fills gaps in the existing evidence base.
However, several challenges remain. The lack of a single clas-
sification and definition for sarcopenia remains one of the
greatest problems for research into sarcopenia, extending be-
yond studies of the association between sarcopenia and oste-
oporosis. Achieving a consensual definition would facilitate
the comparison of results across studies that use a common
definition and would help translation of the findings into clin-
ical practice. Finally, future prospective studies should inves-
tigate the joint association of sarcopenia and osteoporosis,
i.e., ‘osteosarcopenia’, on adverse health outcomes. Binkley
& Buehring were the first to introduce the concept in 2009
as a subset of older adults with both osteoporosis and
sarcopenia.35 Although more studies have been carried out
since that moment,36,37 literature using prospective studies
is lacking.38
Strength and limitations
UK Biobank provided the opportunity to test our hypothesis
in a large and well characterized general population-based
cohort of middle-aged and older adults. Consequently, analy-
ses could be adjusted for multiple potential confounders.
Moreover, incident osteoporosis was ascertained through
linkage primary care records. However, UK Biobank is not
representative of the UK population in terms of socio-
demographic, lifestyle and prevalent disease. Therefore,
while risk estimates can be generalized,39 summary statistics
such as the prevalence or incidence of health conditions
should not.40 Muscle mass was measured using BIA. While
this method is not the gold standard, muscle mass estimated
using BIA has been shown to have good agreement with DXA
(r = 0.868).41 In addition, owing to insufficient statistical
power, we were unable to study severe sarcopenia as a sep-
arate category and therefore, we combined sarcopenia and
severe sarcopenia. Even so, the number of participants in
some sarcopenia categories, especially men, was low,
which likely explains the lack of significant association
for sarcopenic men. Another potential limitation is the
self-reported gait speed. Although we used self-reported
walking pace as a proxy of gait speed, previous studies have
shown that this simple and cheap marker of physical capabil-
ity has a strong predictive ability for chronic diseases and
mortality, even beyond mean fracture risk.42,43 In addition,
even though our analyses adjusted for a large list of con-
founding factors, some of the associations identified might
be due to residual or unmeasured confounding. Finally, the
observational nature of the study does not allow us to infer
causality from the association; therefore, future trials should
investigate the potential causal link of sarcopenia and physi-
cal capability markers with osteoporosis.
In conclusion, our findings demonstrated that
pre-sarcopenic men and sarcopenic women had a higher risk
of incident osteoporosis even after adjustment for a large
range of potential confounders. Since sarcopenia could be
prevented, early public health strategies aimed at improving
physical capability may help to prevent or delay some cases
of osteoporosis. Randomized trials would help address this
question.
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